Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

NCT05323734 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberous Sclerosis Complex

Interventions

DRUG: Ganaxolone
DRUG: Placebo

Sponsor

Marinus Pharmaceuticals